CEP-33457

DRUG2 trials

Sponsors

Cephalon, Inc.

Conditions

Systemic Lupus Erythematosus

Phase 2

A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE)

CompletedNCT01135459

Cephalon, Inc.Systemic Lupus Erythematosus

Start: 2010-06-24End: 2012-06-30Updated: 2022-12-16

Phase 3

A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Participants With Systemic Lupus Erythematosus

TerminatedNCT01240694

Cephalon, Inc.Systemic Lupus Erythematosus

Start: 2010-12-09End: 2012-06-14Updated: 2022-12-30